As an involved Board Member and Outreach Committee chair of The Bioscience Network (TBN), Denise is thrilled to announce the upcoming leadership event held at the Law offices of Bingham McCutchen on Thursday, October 24, 2013.
One of the biggest challenges in the drug development industry is how leaders and their organizations thrive through enormous disruptive events, both positive and negative. Whether it is a Phase II/III clinical trial result, a merger or acquisition, or an FDA approval and commercialization, these major catalytic events have enormous impact on companies, their business plans, their staff, and their culture. Come hear from our panel of biotech/pharma leaders who have gone through major disruptive change. Learn about the best practices they have implemented to deal with these daunting challenges. Register here.
Learn more about The Bioscience Network (TBN) at www.thebiosciencenetwork.org